Humacyte’s tissue-engineered blood vessel for vascular trauma gets nod
Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s.
Drugs
Medical
Pharma
Amgen Inc., to invest $1 billion to build a second plant in North Carolina
Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a.
Climate
Drugs
Medical
Baxter plans to limit stockpiling of its drugs after Hurricane Helene
US-based Baxter International Inc., is implementing an allocation policy to limit stockpiling of its drugs after Hurricane Helene ripped through its facility in.
Drugs
Health
Pharma
J&J to build $2b facility in North Carolina to make future products
HQ Team October 2, 2024: Johnson & Johnson will invest $2 billion to build a biologics manufacturing facility in Wilson, North Carolina, anticipating.
Drugs
Health
Pharma
Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.